Vertaling van "new vaccine menveo was also launched " (Nederlands → Frans) :

The new vaccine Menveo was also launched in March after US and European regulatory approvals for initial use from age 11 and older against four meningococcal meningitis serogroups.
Le nouveau vaccin Menveo a été lancé en mars après avoir été homologué aux Etats-Unis et en Europe pour une utilisation initiale à partir de l’âge de 11 ans contre quatre sérogroupes de la méningite à méningocoque.

In addition to the exceptional sales contributions from A (H1N1) pandemic vaccines, Vaccines and Diagnostics is launching the new Menveo vaccine in the US and Europe while expanding in targeted emerging markets.
Outre ses contributions provenant des ventes exceptionnelles des vaccins contre la pandémie de grippe A (H1N1), Vaccins et Diagnostic lance le nouveau vaccin Menveo aux Etats-Unis et en Europe tout en poursuivant son expansion dans des marchés émergents ciblés.

Menveo, which was submitted in 2008 for US regulatory approval as a new vaccine to protect against four common types of meningococcal meningitis in people age 11-55, has received a Complete Response letter from the FDA requesting additional information on the submission’s clinical and CMC (Chemistry Manufacturing and Control) sections.
Menveo, a été soumis en 2008 aux autorités sanitaires américaines en vue d’obtenir son autorisation en tant que vaccin contre quatre types communs de méningite à méningocoques chez les personnes âgées de 11 à 55 ans. Ce médicament a reçu de la FDA une «Complete Response letter» demandant des informations complémentaires sur les sections Clinique et CMC (Chemistry Manufacturing and Control) du dossier.

Menveo (MenACWY-CRM) was submitted in August for US approval and in October for EU approval as a new vaccine to protect against four common types of meningococcal meningitis known as A, C, W-135 and Y for this often-fatal bacterial infection.
Menveo (MenACWY-CRM) a fait l’objet d’une demande d’enregistrement en août aux Etats-Unis et en octobre dans l’UE, en tant que nouveau vaccin contre quatre types communs de méningite à méningocoque dénommés A, C, W135 et Y, de ces infections bactériennes souvent fatales.

NEW YORK , N.Y., December 12 - Pfizer Inc. announced that Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) was introduced into the first childhood immunization program for pneumococcal disease (PD) in the developing world under the auspices of the Advance Market Commitment (AMC) when Nicaragua launched its program today .
NEW YORK , N.Y., December 12 - Pfizer Inc. announced that Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) was introduced into the first childhood immunization program for pneumococcal disease (PD) in the developing world under the auspices of the Advance Market Commitment (AMC) when Nicaragua launched its program today .